Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIG Regulatory News (SHI)

Share Price Information for SIG (SHI)

Share Price is delayed by 15 minutes
Get Live Data
8.03    -0.12 (-1.47%)
Bid:
8.02
Ask:
8.10
Spread: 0.08 (0.998%)
Market Cap: £92.81m
SHI Live PriceLast checked at - London Stock Exchange

Intraday SIG Share Chart

Director/PDMR Shareholding

13 Mar 2023 15:49

RNS Number : 7971S
SIG PLC
13 March 2023
 

 

13 March 2023

 

SIG plc

("SIG" or the "Company")

Notification and public disclosure of Deferred Share Awards to Directors/Persons Discharging Managerial Responsibilities and their Closely Associated Persons

 

LEI: 213800VDC1BKJEZ8PV53

 

SIG plc announces that on 10 March 2023, the following awards were granted over the Company's Ordinary Shares of 10 pence each ("Shares") under the SIG plc Bonus Plan to certain directors / persons discharging managerial responsibility ("PDMRs") of the Company.

 

Name

Status

Number of Shares under the Deferred Share Awards

Option Price

Ian Ashton

Chief Financial Officer

505,572

£Nil

 

The SIG plc Bonus Plan provides that, in accordance with the Directors' Remuneration Policy approved by shareholders in 2020, for each Executive Director one-third of his annual bonus earned up to 100% of his annual salary is to be deferred into Shares and that all bonus earned above 100% of salary is to be deferred into Shares (the "Deferred Share Awards").

 

The number of Shares granted under the Deferred Share Awards has been calculated using a price of 40 pence per Share being the closing share price on 9 March 2023. No consideration was paid for the grant of the Deferred Share Awards which are structured as nil cost options.

 

The normal vesting date for the Deferred Share Awards will be 10 March 2026, being the third anniversary of the award date. Once vested, the Deferred Share Awards will normally be exercisable until the day before the tenth anniversary of the award date. The Shares that are the subject of the Deferred Share Awards are subject to a further two-year holding period commencing on vesting. 

 

This announcement and the following disclosures are made in accordance with Article 19 of the UK Market Abuse Regulation.

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Ian Ashton

2

Reason for the notification

a)

Position/status

PDMR (Chief Financial Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

SIG plc

b)

LEI

213800VDC1BKJEZ8PV53

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p

 

ISIN: GB0008025412

b)

Nature of the transaction

Grant of Deferred Share Awards for nil consideration

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

GBP Nil

505,572

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transaction

e)

Date of the transaction

10 March 2023

f)

Place of the transaction

Outside a trading venue

 

 

 

Enquiries:

 

 

 

 

SIG plc

 

 

Andrew Watkins

Group General Counsel & Company Secretary

+44 (0) 114 285 6300

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSFWFIDEDSELD
Date   Source Headline
3rd Jun 20263:50 pmRNSDirector/PDMR Shareholding
28th May 20262:56 pmRNSDirector/PDMR Shareholding
22nd May 20261:36 pmRNSDirector/PDMR Shareholding
22nd May 20261:29 pmRNSDirector/PDMR Shareholding
22nd May 20261:18 pmRNSResult of Meeting
20th May 20263:07 pmRNSDirector/PDMR Shareholding
14th May 20264:44 pmRNSDirector/PDMR Shareholding
13th May 20265:27 pmRNSDirector/PDMR Shareholding
6th May 202611:11 amRNSDirector/PDMR Shareholding
6th May 202610:24 amRNSNotice of GM
30th Apr 20262:00 pmRNSResult of AGM
30th Apr 20267:01 amRNSTrading Update
30th Apr 20267:00 amRNSAppointment of Chief Financial Officer
10th Apr 20267:00 amRNSDirectorate change
23rd Mar 202610:57 amRNSDirector/PDMR Shareholding
23rd Mar 20269:59 amRNSNotice of AGM
4th Mar 202610:18 amRNSAnnual Financial Report
4th Mar 20267:00 amRNSFull year results for year ended 31 December 2025
15th Jan 20264:02 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNS2025 Full Year Trading Update & Strategy Framework
19th Dec 20257:00 amRNSNotice of Trading & Business Update
19th Dec 20257:00 amRNSNotice of Trading & Business Update
23rd Oct 202511:05 amRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSQ3 Trading Update
1st Oct 20259:00 amRNSDirector/PDMR Shareholding
3rd Sep 202510:54 amRNSHolding(s) in Company
28th Aug 20251:02 pmRNSResult of Meeting
8th Aug 202511:01 amRNSNotice of GM
5th Aug 20257:00 amRNSResults for the six months to 30 June 2025
8th Jul 20257:01 amRNSAppointment of CEO and Chair designate
8th Jul 20257:00 amRNSH1 Trading Update
9th May 20257:00 amRNSDirectorate Change
6th May 20253:00 pmRNSHolding(s) in Company
1st May 20253:12 pmRNSResult of AGM
30th Apr 20257:00 amRNSTrading Update
10th Apr 20254:02 pmRNSDirector/PDMR Shareholding
4th Apr 202511:10 amRNSDirector/PDMR Shareholding
1st Apr 20254:00 pmRNSHolding(s) in Company
28th Mar 20255:03 pmRNSDirector/PDMR Shareholding
28th Mar 20254:59 pmRNSDirector/PDMR Shareholding
24th Mar 202510:06 amRNSNotice of AGM
21st Mar 20254:44 pmRNSDirector/PDMR Shareholding
12th Mar 20259:06 amRNSDirector/PDMR Shareholding
12th Mar 20258:54 amRNSDirectorate Change
10th Mar 20258:32 amRNSDirector/PDMR Shareholding
5th Mar 202511:17 amRNSAnnual Financial Report
5th Mar 20257:00 amRNSFull year results for year ended 31 December 2024
4th Mar 202512:52 pmRNSHolding(s) in Company
19th Feb 20257:00 amRNSHolding(s) in Company
30th Jan 20255:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.